MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation
Stickel, N, Hanke, K, Marschner, D, Prinz, G, Köhler, M, Melchinger, W, Pfeifer, D, Schmitt-Graeff, A, Brummer, T, Heine, A, Brossart, P, Wolf, D, von Bubnoff, N, Finke, J, Duyster, J, Ferrara, J, Salzer, U, Zeiser, R
Published in Leukemia (01.12.2017)
Published in Leukemia (01.12.2017)
Get full text
Journal Article
The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib
Albers, C, Leischner, H, Verbeek, M, Yu, C, Illert, A L, Peschel, C, von Bubnoff, N, Duyster, J
Published in Leukemia (01.06.2013)
Published in Leukemia (01.06.2013)
Get full text
Journal Article
Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors
Tomiatti, V, Istvánffy, R, Pietschmann, E, Kratzat, S, Hoellein, A, Quintanilla-Fend, L, von Bubnoff, N, Peschel, C, Oostendorp, R A J, Keller, U
Published in Oncogene (13.08.2015)
Published in Oncogene (13.08.2015)
Get full text
Journal Article
The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107
VON BUBNOFF, N, GORANTLA, S. H. P, KANCHA, R. K, LORDICK, F, PESCHEL, C, DUYSTER, J
Published in Leukemia (01.09.2005)
Published in Leukemia (01.09.2005)
Get full text
Journal Article
The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro
von Bubnoff, N, Gorantla, S P, Engh, R A, Oliveira, T M, Thöne, S, Åberg, E, Peschel, C, Duyster, J
Published in Oncogene (24.02.2011)
Published in Oncogene (24.02.2011)
Get full text
Journal Article
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib
Miething, C, Feihl, S, Mugler, C, Grundler, R, von Bubnoff, N, Lordick, F, Peschel, C, Duyster, J
Published in Leukemia (01.04.2006)
Published in Leukemia (01.04.2006)
Get full text
Journal Article
Compensatory PI3-kinase Akt mTor activation regulates imatinib resistance development
BURCHERT, A, WANG, Y, CAI, D, VON BUBNOFF, N, PASCHKA, P, MÜLLER-BRÜSSELBACH, S, OTTMANN, O. G, DUYSTER, J, HOCHHAUS, A, NEUBAUER, A
Published in Leukemia (01.10.2005)
Published in Leukemia (01.10.2005)
Get full text
Journal Article
A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor
von Bubnoff, Nikolas, Veach, Darren R., van der Kuip, Heiko, Aulitzky, Walter E., Sänger, Jana, Seipel, Petra, Bornmann, William G., Peschel, Christian, Clarkson, Bayard, Duyster, Justus
Published in Blood (15.02.2005)
Published in Blood (15.02.2005)
Get full text
Journal Article
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
Zeiser, R, Burchert, A, Lengerke, C, Verbeek, M, Maas-Bauer, K, Metzelder, S K, Spoerl, S, Ditschkowski, M, Ecsedi, M, Sockel, K, Ayuk, F, Ajib, S, de Fontbrune, F S, Na, I-K, Penter, L, Holtick, U, Wolf, D, Schuler, E, Meyer, E, Apostolova, P, Bertz, H, Marks, R, Lübbert, M, Wäsch, R, Scheid, C, Stölzel, F, Ordemann, R, Bug, G, Kobbe, G, Negrin, R, Brune, M, Spyridonidis, A, Schmitt-Gräff, A, van der Velden, W, Huls, G, Mielke, S, Grigoleit, G U, Kuball, J, Flynn, R, Ihorst, G, Du, J, Blazar, B R, Arnold, R, Kröger, N, Passweg, J, Halter, J, Socié, G, Beelen, D, Peschel, C, Neubauer, A, Finke, J, Duyster, J, von Bubnoff, N
Published in Leukemia (01.10.2015)
Published in Leukemia (01.10.2015)
Get full text
Journal Article
Successful allogeneic stem cell transplantation in second chronic-phase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib
Menzel, H, von Bubnoff, N, Hochhaus, A, Haferlach, C, Peschel, C, Duyster, J
Published in Bone marrow transplantation (Basingstoke) (01.07.2007)
Published in Bone marrow transplantation (Basingstoke) (01.07.2007)
Get full text
Journal Article
Lenvatinib and pembrolizumab as save and effective combination treatment in 8 patients with metastasized anaplastic (ATC) or poorly differentiated thyroid carcinoma (PDTC)
Dierks, C., Miething, C., Thomusch, O., von Bubnoff, N., Duyster, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
B symptoms in unexplained mediastinal lymphadenopathy : Case report of a 72-year-old male patient with VEXAS syndrome
Ripke, A, Münchau, A, von Bubnoff, N, Jendrek, S, Kopelke, S, Kümpers, C, Parschke, P, Schinke, S, Khandanpour, C
Published in Innere Medizin (Heidelberg, Germany) (01.08.2023)
Published in Innere Medizin (Heidelberg, Germany) (01.08.2023)
Get full text
Journal Article
P484: WHOLE EXOME SEQUENCING (WES) CHARACTERIZES THE MUTATIONAL LANDSCAPE OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
Witte, H., Kuenstner, A., Schwarting, J., Bernard, V., Merz, H., Bubnoff, N., Busch, H., Feller, A., Gebauer, N.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P1233: PRIMARY REFRACTORY PLASMABLASTIC LYMPHOMA: A PRECISION ONCOLOGY APPROACH
Witte, H., Fähnrich, A., Riedl, J., Kuenstner, A., Hertel, N., Bubnoff, N., Merz, H., Busch, H., Feller, A., Gebauer, N.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1232: PRINCIPLES OF PRECISION ONCOLOGY IN PRIMARY REFRACTORY HIGH‐GRADE B‐CELL LYMPHOMA WITH MYC‐, BCL2 AND/OR BCL6 REARRANGEMENTS (HGBL‐DH/TH)
Witte, H., Faehnrich, A., Riedl, J., Kuenstner, A., Ketzer, J., Bubnoff, N., Merz, H., Busch, H., Feller, A., Gebauer, N.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article